Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography-based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

From bionic eyes to cell and gene therapies in clinical therapies, it's an exciting time for emerging technologies aiming to ...

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found.

Cornerstone Eye Associates has become the first practice in Rochester to offer Valeda Light Therapy for the treatment of dry ...

In a new study from SUNY College of Optometry to be published in Cell Reports, Maharjan et al. demonstrate that human ...

Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people ...

After Hrithik Roshan said his eye power reduced, it is important to know that vision may improve functionally, not structurally. Lifestyle changes, reduced screen strain, nutrition, and vision therapy ...

Researchers at Johns Hopkins University have discovered a new cellular mechanism behind how humans ...

On Wednesday, January 28, the Speaking of Psychology podcast, hosted by Kim Mills, released an episode featuring Joel Pearson ...

Chief Executive Officer Craig Parker used a discussion at a 2026 investor summit to outline the company’s focus on Wnt pathway biology and antibody engineering, with an emphasis on retinal vascular ...

Based on this research output, EYEREUM Eye Clinic currently participates as a member institution of the Korean Ophthalmological Society’s LASIK and LASEK Committee, which reviews clinical ...